The European Medication Agency consulted on the 3rd and 4th generation pills

Publié le : 29 March 2013

 At a meeting of the Environment and Health Commission of the European Parliament, "the European MP, vice-chairperson of the Green Party, called on the European Medication Agency" [EMA]  to make its position clear on the 3rd and 4th generation contraceptive pills, and stated: "What we see today is only the tip of the iceberg of a huge scandal on the way.

Recently, she pointed out, the French National Medication Agency had published "a report in which it announced that between 2000 and 2011, the contraceptive pill had provoked each year over 2,500 blood-clotting accidents and 20 deaths (of which 14 were attributable to the 3rd and 4th generation pills). It was only when France approached the EMA that Europe at last took an interest in this issue." The European MP added: "if there have been so many complaints up to the present in Europe, this is due above all to the fact that there have not been enough reports of the secondary effects of these medications made by doctors and gynaecologist and by the patients themselves who are unaware that they can signal these effects to the Eudravigilances database. It is the pharmaceutical laboratories that do all the work for the assessment of risks. But, as judges and parties, these laboratories report to the EMA only the most pertinent information." She ended by putting a question: "European pharmacies regularly dispense contraceptive pills without a prescription. How can we know the real figures for the victims of a stroke or other accidents if no doctor has monitored these women and if the accidents were not reported to the EMA?"

Share this article

BIOETHICS PRESS SYNTHESIS